The PEERLESS II Study
NCT: NCT06055920 · RECRUITING
NCT IDNCT06055920
StatusRECRUITING
Start Date2023-11-17
Completion2026-07
Brief Summary
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.
Frequently Asked Questions
What is The PEERLESS II Study?
The PEERLESS II Study is a clinical trial registered under NCT06055920. Current status: RECRUITING.
What is the status of NCT06055920?
The current status of NCT06055920 (The PEERLESS II Study) is: RECRUITING.
When did The PEERLESS II Study start?
The PEERLESS II Study started on 2023-11-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.